MYH11 is involved in the translocation with core binding factor β (CBFβ) that is typical of 10% of adults with AML [34] and has been shown to target RUNX/ETS-factor binding sites and drive leukaemogenesis through the modulation of H3ac levels [35]. The gene discussed is CBFB; the disease is acute myeloid leukemia.